As you may know, in recent years, certain subsidiaries of Imerys Group have faced cosmetic talc-related litigation in the U.S. on alleged hazards related to the use of talc in certain products. While we continue to believe these claims are without merit, the growing number of talc-related lawsuits in the U.S. would lead to overwhelming long-term legal defense costs for our business associated with the specific nature of the U.S. judicial system’s handling of product liability claims.
To resolve the uncertainty surrounding this litigation and best position our business for sustained growth in the future, the North American talc subsidiaries of Imerys have filed for Chapter 11 protection under U.S. law. This determination was made after reviewing all possible options. Filing for Chapter 11 protection allows us to continue business as usual – to serve our customers with the same high standards we always have – while we work to achieve our financial and legal goals. Through this action, we have laid the groundwork to efficiently emerge from the Chapter 11 process having resolved our historic talc-related liabilities.
Our talc is safe. Imerys believes strongly and continues to maintain that the ongoing talc-related litigation in the U.S. is without merit. Imerys is committed to the quality and safety of our products through our product stewardship programs. We employ state-of-the-art analytical capabilities, equipment, and testing to ensure the assessments of our products are driven by sound science. We comply with all applicable regulations in all jurisdictions where we make and sell products, and we are continually evaluating opportunities to improve our testing protocols across ores/minerals to align our processes with the most up-to-date science and developments.
The safety of talc has been confirmed by dozens of peer-reviewed studies, as well as multiple regulatory and scientific bodies. This data confirms that talc is not carcinogenic. However, it is simply not in the best interest of our stakeholders to litigate in perpetuity.
We understand that you may have questions as to how this impacts our relationship. In short, we do not expect that customers will see any change. Chapter 11 allows companies to continue to operate normally while working to achieve their goals, which is exactly what we intend to do. Our business is continuing to operate as usual throughout this process and we fully intend to satisfy all customer obligations.
We remain committed to delivering safe, high-quality products to our customers and, looking ahead, we are confident this will make us an even stronger partner. In the meantime, we are dedicated to keeping you informed throughout this process. Please feel free to reach out to your normal company contact with any questions. Additionally, we’re happy to schedule an in-person meeting if you’d prefer.
Thank you for your
continued support. We look forward to continuing to work together.
How do I know what entity I contract with?
The best way to confirm which Imerys entity you contract with is to review the contract itself. However, if you have any questions, please don’t hesitate to contact your normal company contact.
Will the Chapter 11 filing impact my relationship with Imerys Talc America/Imerys Talc Canada/Imerys Talc Vermont?
We are operating as usual. We remain committed to delivering safe, high-quality products to our customers.
How do you comply with country-specific regulations on talc?
Imerys complies with all applicable regulations in all jurisdictions where we make and sell products, and we are continually evaluating opportunities to improve our testing protocols across ores/minerals to align our processes with the most up-to-date science and developments. If you have additional questions, please contact ProductStewardship@imerys.com and refer to the latest Compliance Certificate Talc Regulatory Profile.
Is there anything I need to do to ensure I receive product shipments? Should I expect any interruptions to my orders moving forward?
No. Imerys and all of its subsidiaries, whether included in the filing or not, are operating normally.
How will I be kept informed during this process?
We will keep you informed on a timely basis as things develop, however if you have any questions in the interim please direct them to your normal day-to-day contact.